Nat1 (also known as p97/Dap5/Eif4g2) is a ubiquitously expressed cytoplasmic protein that is homologous to the C-terminal two thirds of eukaryotic translation initiation factor 4G (also known as Eif4g1). We previously showed that Nat1-null mouse embryonic stem cells (mESCs) were resistant to differentiation. In the current study, we found that NAT1 and eIF4G1 share many binding proteins, such as eIF3, eIF4A and ribosomal proteins. However, NAT1 did not bind to eIF4E or poly A binding proteins, which are critical for cap-dependent translation initiation. In contrast, compared to eIF4G1, NAT1 preferentially interacts with eIF2, FMR and related proteins, and especially PRRC2 family members. We also found that Nat1-null mESCs possess a transcriptional profile similar, though not identical, to ground state, which is established in wild-type mES cells when treated with inhibitors of the ERK and GSK3 signaling pathways. In Nat1-null mESCs, the ERK pathway is suppressed even without inhibitors. Ribosome profiling revealed that translation of Map3k3 and Sos1 is suppressed in the absence of Nat1. Forced expression of Map3k3 induced differentiation of Nat1-null mESCs. These data collectively show that Nat1 is involved in translation of proteins that are required for cell differentiation.
INTRODUCTION
NAT1, also known as eIF4G2, p97, and DAP5, were identified and reported by multiple groups in 1997 (1) (2) (3) (4) . NAT1 is homologous to the C-terminal two thirds portion of eukaryotic initiation factor (eIF) 4G (also known as eIF4G1), suggesting its role in translation (5) (6) (7) . In mammalian cells, translation is initiated by many initiation factors and other RNA binding proteins. A key initiation factor is the 7-methylguanosine (m7G) cap-binding complex eIF4F composed of the cap-binding subunit eIF4E, the scaffold eIF4G and the helicase eIF4A. The small ribosomal preinitiation complex loaded with a multifactor complex including eIF2:GTP:Met-tRNAi ternary complex and eIF3 is initially recruited to the 5' m7G-cap of mRNA via eIF4F and then moves in the 3' direction scanning for the initiation codon (8, 9) . The eIF4A helicase unwinds secondary structures in the 5' untranslated region. Being comprised of 13 subunits, the largest factor eIF3 interacts with the solvent side of the small ribosomal subunit, mediating functional placement of other initiation factors. eIF4G1 forms the major contact site with the preinitiation complex. NAT1 binds to eIF4A (1, 2) and eIF3 (2), but not to eIF4E (1, 2) . Therefore it has been suggested that NAT1 is involved in non-canonical, cap-independent translation initiation of specific mRNAs. However, the precise mode of action on NAT1 and its target mRNAs are still largely unknown. In order to elucidate physiological functions of NAT1, we previously knocked out its gene in mice (10) . Nat1-null mice were lethal in uterus, prior to implantation, demonstrating its critical role in early development.
To further study the role of Nat1 in cell differentiation, we generated mouse embryonic stem cells (mESCs) lacking both alleles of the Nat1 gene. mESCs were derived from blastocysts in 1981 (11, 12) and possess two unique properties. First, ESCs have the potential to self-renew indefinitely (maintenance). Secondly, ESCs have the potential to differentiate into all somatic and germ cell types (pluripotency) that make up the body. We found that even in the absence of Nat1, mESCs could self-renew and maintain indefinite growth properties (10) . In marked contrast, when we tried to induce differentiation by removing feeder cells or by treating with retinoic acid, Nat1-null mESCs failed to differentiate properly. These data demonstrated that Nat1 is critical for pluripotency, but not maintenance of mESCs.
A few years after our demonstration of the differentiationdefective phenotype of Nat1-null mESCs, Ying et al. reported that mESCs acquire homogeneously and completely undifferentiated status by treating with inhibitors of the Erk and Gsk3b kinase pathways (13) . They designated this state "ground state". We noticed that the morphology of Nat1-null mES cells were similar to that of the ground state induced by the kinase inhibitors, suggesting that Nat1 deletion may result in changes that are similar to the ground state. In the current study, we analyzed Nat1-null mESCs in more details to examine whether they are indeed in the ground state. We also performed immunoprecipitation (IP), mass spectrometry (MS) and ribosome profiling analyses to better understand molecular interactions and translational impact of Nat1.
RESULTS

Nat1
-null mESCs show a status similar but not identical to ground state. Nat1-null mESCs maintained in the standard ESC culture condition with leukemia inhibitory factor (LIF) showed a round dome-like morphology, which resembled that of wild-type mESCs (WT mESCs) cultured with the two kinase inhibitors and
Significance
We have previously shown that NAT1, which is homologous to the C-terminal two thirds of eukaryotic translation initiation factor (eIF) 4G, is essential for differentiation of mouse embryonic stem cells (mESCs). In the current study, we demonstrated that Nat1 supports translation of Map3k3 and Sos1. Deletion of Nat1 resulted in decreased protein levels of these factors, resulting in suppression of the Erk and Akt signally pathway. Forced expression of Map3k3 induced differentiation in Nat1-null mESCs. Thus Nat1 is involved in translation of proteins that are required for differentiation of mESCs. Fig. 1 . Nat1-null mESC shows a status similar, but not identical to ground state. (A) The morphology of WT mESCs and Nat1-null mESCs cultured in LIF or 2i+LIF condition 3 days after reseeding on gelatin-coated dishes. (B) Scatter plots of transcript expressions in Nat1-null mESCs and WT mESCs. The expression values are shown on a log 2 scale. Red dots indicate probes with significantly different expressions (n = 3, two-fold, FDR < 0.05) between the x axis and y axis samples; blue indicates core transcription factors enriched in the ground state that are expressed more than 2-fold in x axis than in y axis; green indicates those that are expressed more than 2-fold in y axis; black indicates those with no significant difference between the x and y axes. (C) Violin plots of Ct value (log 2 scale) of the mRNA expression in single cell. Samples were collected 3 days after reseeding on gelatin-coated dishes. (D) PCA and hierarchical clustering analyses of WT and Nat1-null mESCs.
Submission PDF
leukemia inhibitory factor (2i+LIF) (Fig. 1A) . To compare gene expression between Nat1-null mESCs and WT mESCs, we per- formed microarray analyses (Fig. 1B) . In WT mESCs, the mRNA expressions of several transcription factors, including Nanog, Esrrb, Klf2, Klf4, Tbx3, Pou5f1 (also known as Oct3/4) and Tfcp2l1 were increased significantly when treated with 2i+LIF (shown in red in Fig. 1B, upper left panel) . Even without 2i, Nat1-null mESCs showed higher expression levels of transcription factors which are more highly expressed in the ground state relative to the primed state (Fig. 1B , lower left panel), which were comparable to those in 2i+LIF treated WT mESCs (Fig. 1B, upper right  panel) . The 2i treatment did not induce further increase of these genes in Nat1-null mESCs (Fig. 1B, lower right panel) . Single cell quantitative RT-PCR (qRT-PCR) also demonstrated that Nat1-null mESCs were similar to ground state in higher and more uniform expression of several key transcription factors ( Figure 1C) . However, the global gene expression was not identical between Nat1-null mESCs and the ground state mESCs: many genes were differentially expressed (Fig. 1B, upper right panel) . Principal Component Analysis (PCA) and hierarchical clustering analysis confirmed that gene expression profile of Nat1-null mESCs were similar, but not identical to that of the ground state mESCs. (Fig.  1D) .
Intercellular signaling in Nat1-null ESCs. In order to address the effects of Nat1 deletion on intracellular signaling, we performed western blot analyses (Fig. 2) . We confirmed that the expression of OCT3/4, NANOG, and TBX3 increased in Nat1-null mESCs to similar degrees with the ground state mESCs ( Fig. 2A and B) . Of note, we found that the phosphorylation level of ERK1/2 markedly decreased whereas that of STAT3 was increased in Nat1-null mESCs, to similar levels in the ground state ( Fig. 2A and C) . In contrast, phosphorylation of other signaling molecules, including GSK3β and p38 did not change. We also observed decreased phosphorylation of AKT in Nat1-null mESCs. These data demonstrated that specific signaling pathways are altered as a result of Nat1 deletion. NAT1 and EIF4G1 form unique translational complexes. To identify NAT1-binding proteins, we prepared mESCs in which 3×FLAG tag was knocked into the 3' end of Nat1 and Eif4g1 coding region by using the CRISPR/Cas9 system (14) (Fig. 3A) . After immunoprecipitation with an anti-FLAG antibody, we identified co-immunoprecipitated proteins by mass spectrometry (MS) analysis with the iTRAQ system, which precisely measures relative peptide abundances. We found that NAT1 and eIF4G1 shared many binding proteins, such as eIF4A1 and 2, ribosomal proteins, and all 13 eIF3 subunits except eIF3j, which is a loosely associated subunit (Table 1) . NAT1 does not bind to eIF4E as previously reported (1, 2) . In addition, eIF4G1, but not NAT1, strongly bound to poly A binding protein, PABPC1 and cleavage and polyadenylation specificity factor CPSF3. Importantly, NAT1 preferentially bound to eIF2 (15) , FMR1, FXR1 (16) and members of proline-rich coiled-coil protein 2 family, including PRRC2A, PRRC2B, and PRRC2C (Table 1) . Western blot confirmed preferential binding of eIF2α, FMR1 and FXR1 to NAT1 (Fig. 3B) . Thus NAT1 and eIF4G1 form overlapping, but yet unique protein complexes (Fig. 3C) .
Suppressed translation of MAP3K3 and SOS1 in Nat1-null mESCs. To identify mRNAs translationally regulated by NAT1, we performed ribosome profiling (17) , which quantifies the ribosome-protected mRNA fragment (RPF) to determine translationally active regions on mRNA ( Figure 4B & Table S2 ). We compared wildtype (WT), Nat1 heterozygous (Nat1 +/-), and Nat1- null (Nat1 -/-) mESCs. Nat1 +/-mESCs show normal phenotype in development and have the same characteristics as WT mESCs (10) . First, we visualized mapped fragments for the Nat1 gene locus (Fig. 4A) . Total mRNA signals showed that the exons 1 and 2 were not expressed in Nat1-null mESCs, consistent with our targeting strategy with which we eliminated the second exon containing the translational initiation codon. Interestingly, the remaining exons were still expressed, but the signals of the 3' half portion decreased compared to WT and Nat1 +/-mESCs. This may be attributable to non-sense mediated RNA decay (18) . In marked contrast, RPF signals in Nat1-null mESCs were not detected throughout the coding sequence regions, reflecting a depletion of Nat1 translation due to the absence of the start codon. Next, we compared the normalized counts of total fragments and RPF mapped to each gene using the Xtail pipeline (19) , which has been developed to identify genes differentially translated. As a result, we identified 18 genes (14 decreased and 4 increased), of which translation differed more than two-fold between WT and Nat1-null mESCs and between Nat1 +/-and Nat1-null mESCs (Fig. 4B ). Of note, translationally suppressed genes included Map3k3 and Sos1, which have been reported as upstream of Erk1/2 in the MAPK pathway (20, 21) . The RPF/total ratios of Map3k3 and Sos1 were significantly lower in Nat1-null mESCs than in WT mESCs or Nat1 +/-mESCs ( 273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339 Log2 expression values in Nat1-null mESCs were set to 0 (n = 3). Error bars indicate SD. Significant differences from the corresponding Map3k3-expressing Nat1-null mESCs at *, p < 0.05; **, p < 0.01; Dunnett's test.
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Forced expression of Map3k3 induced differentiation in Nat1-null mESCs. To determine whether Map3k3 and Sos1 can rescue the differentiation-defective phenotypes of Nat1-null mESCs, we introduced tet-inducible Map3k3-or EGFP-, as well as Sos1-or DsRed-expressing cassettes into Nat1-null mESCs. In the absence of doxycycline (Dox), these cells maintained the round domeshape morphology, typical to Nat1-null mESCs ( Fig. 5A and B) . In marked contrast, Map3k3-expressing Nat1-null mESCs showed a morphological change indicative of differentiation after addition of dox at final concentration of 0.02 μg/ml. In these cells, phosphorylation of ERK was reverted to WT level (Fig. 5C) . The mRNA expressions of several pluripotency-related transcription factors including Nanog, Pou5f1, Sox2, Esrrb and Klf4 decreased significantly in these cells (Fig. 5D ). In addition, mRNA expression levels of differentiation markers including Gata3, Gata6, Sox17 and Foxa2 increased (Fig. 5E) . The transcript levels of Brachyury (also known as T) and Fgf5 did not change. Sos1-expressing Nat1-null mESCs did not change morphologically after adding dox. Therefore, these data indicated that the suppressed translation of Map3k3 partially contribute to impaired differentiation of Nat1-null mESCs.
DISCUSSION
In this study, we showed that Nat1 deletion resulted in a status similar, but not identical to ground-like state, which is in normally induced by kinase inhibitors. Immunoprecipitation followed by MS analyses demonstrated that NAT1 interactions are distinct from those of eIF4G1. In addition, ribosome profiling showed that NAT1 is involved in translation of proteins that play critical roles in cell differentiation.
MEK inhibition is critically important in the induction of the ground state (13) . It alone can induce the ground status, albeit in an unstable manner. We found that translation of MAP3K3 and SOS1 was suppressed in the absence of Nat1. The two proteins are involved in the ERK signaling pathway at different levels. Map3k3 is one of many MAP kinase kinase kinases and activate ERK and other MAP kinases (20) . Sos1 is one of the Ras-specific guanine nucleotide exchange factors (GNEFs), which convert Ras from inactive Ras⋅GDP to active Ras⋅GTP (22) . Inactivation of these genes in mice resulted in MAPK activity and developmental defect in uterus (23, 24) . We also found that forced expression of Map3k3 induced differentiation in Nat1-null mESCs. Therefore, it is reasonable to consider that translational suppression of these two proteins, at least in part, contributes to the observed attenuation of the ERK signal and the ground state-like property in Nat1-null mESCs.
Both Map3k3 and Sos1 mRNAs have short upstream ORFs (uORFs). Because uORFs are considered to be translational repressors (25, 26) , we hypothesize that these elements repress translation of these mRNAs after cell differentiation. In WT mESCs, we propose that Nat1 alleviates this translational repression through direct mRNA recruitment without involving eIF4E (see a model in Fig. 3C ). Further mechanistic studies will be required to conclude whether NAT1 mediates cap-independent translation of these mRNAs.
One important question is how NAT1 associates with mRNA to support cap-independent translation. Our MS analyses identified that NAT1 was co-immunoprecipitated with many eIFs and RNA-binding proteins. Some of them were preferentially bound to NAT1, compared to eIF4G1. These include FMR1 and its homologue FXR proteins, and PRRC2 proteins. Recently, NAT1, together with FXR1 was shown to mediate non-canonical translation initiation of specific mRNA in quiescence and immature oocytes (16) . PRRC2 proteins have been listed in three previous manuscripts (27) (28) (29) that systemically identified RNA binding proteins. Other than that little is known about functions of PRRC2 proteins. Further studies are required to understand roles of these and other RNA-binding proteins in translation of Map3k3 and Sos1.
In conclusion, we have demonstrated that Nat1 promotes translation of differentiation-promoting proteins in mESCs. Considering the abundant and ubiquitous expression of Nat1, we speculate that its role is not confined to Map3k3 and Sos1. Our data also showed that translation of certain mRNAs may be suppressed by NAT1 (Fig. 4B) . In Nat1-null mESCs, the mRNA expression levels of numerous genes are altered from those of wild-type counterpart. This makes it difficult to estimate translation efficiency from ribosome profiling. Further studies, such as conditional deletion of Nat1 and identification of Nat1-binding proteins for translational regulation, are required to better understanding of cap-independent translational mechanism by Nat1.
MATERIALS AND METHODS
Cell lines and culture conditions. RF8 mESCs were derived from 129/TerSv mice, and Nat1 +/-and Nat1-null mESCs were generated from the RF8 mESC line in our previous study (10) . mESCs were maintained in DMEM (nacalai tesque, 08459-64) containing 15% FBS (Gibco, 10437-028), 50 units/50 μg/ml penicillin/streptomycin (Gibco, 15149-122), 0.11 mM 2-Mercaptoethanol (Gibco, 21985-023), 2 mM L-glutamine (Gibco, 25030-081), 0.1 mM MEM non-essential Amino Acids (Gibco, 1140-050) and leukemia inhibitory factor (LIF), as previously described (30), on 0.1% (w/v) gelatin (Sigma, G1890-500G)-coated dishes. We called this mouse ESC standard medium "LIF", and the medium with two added inhibitors, MEK inhibitor (1 mM PD0325901; Stemgent, Stemgent 04-006) and Gsk3 inhibitor (3 mM CHIR99021; Stemgent, Stemgent 04-004), "2i+LIF" Generation of Nat1-or Eif4g1-3×FLAG knock-in mESCs. The target regions for Nat1 and Eif4g1 were amplified by PCR and subcloned with the 3×FLAG sequence before the stop codon into the pENTR/D-TOPO vector using the Cold Fusion Cloning Kit (System Biosciences, MC010A-1) as targeting vectors. gRNA vectors for Eif4g1 contained the following gRNA target sequences: gRNA Eif4g1 R1, ACAACCGTGATCTACCATCC, and gRNA Eif4g1 F1, GTCTTTTTGGGAGGGATCTC; gRNA vectors for Nat1 contained the following gRNA target sequences: gRNA Eif4g2 R1, GGAAAGGGCCAC-CGGACCCT, and gRNA Eif4g2 F1, GTGGCCCTTTCGGGCTGCCG. To generate Nat1-3×FLAG knock-in ESCs and Eif4g1-3×FLAG knock-in ESCs using the CRISPR/Cas9 system (14), the targeting vectors, gRNA vector sets, and nickase (D10A) (31) expression vectors were co-transfected into WT mESCs (RF8) using Lipofectamine 2000 Reagent (Invitrogen, 11668-019) according to the manufacturer's instructions. 24 hrs after transfection, cells were selected with puromycin (f.c. 1 μg/ml) for 3 passages and picked to isolate each clone.
Generation of tet-inducible Map3k3-, Sos1-expressing Nat1-null mESCs. The ORFs of Map3k3 and Sos1 were amplified by PCR and reacted with pENTR/D-TOPO vector. Each Map3k3 ORF or EGFP ORF was cloned into PB-TAC-ERP2 (32), and each Sos1 ORF or DsRed ORF done into PB-TAG-ERP2 using a Gateway LR reaction (Invitrogen) according to the manufacturer's instructions. To generate tet-inducible Map3k3-, Sos1-expressing Nat1-null mESCs, the PB-TAC-ERP2/Map3k3, PB-TAC-ERP2/EGFP, PB-TAG-ERP2/Sos1 or PB-TAG-ERP2/DsRed vector was transfected into Nat1-null mESCs using Xfect mESC Transfection Reagent (Clontech, 631320) according to manufacturer's instructions. 24 hrs after transfection, cells were selected with puromycin (f.c. 1 μg/ml) for 3 passages. To express the genes, doxycycline (Dox) (f.c. 0.02 μg/ml for Map3k3 and EGFP or 0.125 μg/ml for Sos1 and DsRed) was supplemented with standard mouse ESC medium.
IP-MS sample preparation and data collection. Protein reduction/alkylation, Lys-C/Trypsin digestion (enzyme ratio: 1/100) and desalting of the samples were performed as described previously (33) . After labeling with isobaric tags for relative and absolute quantification (iTRAQ, ABSciex), each peptide sample was suspended and mixed in the loading buffer (0.5% trifluoroacetic acid and 4% acetonitrile) for subsequent nanoLC-MS/MS analysis. NanoLC-MS/MS was performed using a TripleTOF 5600 System (AB Sciex, Foster City, CA) equipped with HTC-PAL autosampler (CTC Analytics, Zwingen, Switzerland). Loaded samples were separated on a self-pulled analytical column (150 mm length, 100 μm i.d.) using a Dionex Ultimate 3000 RSLC nano System (Germering, Germany). The mobile phases consisted of (A) 0.5% acetic acid with 5% DMSO and (B) 0.5% acetic acid in 80% acetonitrile with 5% DMSO (34) . A three step gradient condition of 5-10% B in 5 min, 10-40% B in 60 min, 40-100% B in 5 min was used with a flow rate of 500 μL/min, and a spray voltage of 2300 V was applied. The MS scan range was 300−1500 m/z every 0.25 s. Triplicate analyses were conducted for each sample, and blank runs were inserted between different samples.
IP-MS data analyses. The raw data files were analyzed by ProteinPilot v5.0 (ABSciex, Foster City, CA). Peak lists, which were generated from the ProteinPilot.group file, were then analyzed by Mascot v2.5 (Matrix Science, London, U.K.). Both database search engines were used against UniProt/Swiss-Prot release 2015 06 (27-May-2015) with previously described parameters (33) , with the exception of a precursor mass tolerance of 20 ppm and a fragment ion mass tolerance of 0.1 Da. For protein identification ,   545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 Submission PDF peptides were grouped into "protein groups" based on previously established rules (35) . Then, at least two confidently identified peptides per protein were used for the identification. A minimum peptide length of 6 amino acids and single peptides with higher confidence (p < 0.01) were also used for the identification. False discovery rates (FDRs) were estimated by searching against a decoy sequence database (< 1%). For protein quantification, the intensity of the iTRAQ label spectra was normalized by i-Tracker perl script (36) , and the median value of the iTRAQ label ratio was calculated for each protein.
Single-cell expression quantitative RT-PCR analysis. Single cells were captured on a C1 Single-Cell Autoprep System with an integrated fluidic circuit (IFC) chip for cells 10-17 µm long (Fluidigm, 100-5480), and the cDNAs were pre-amplified using the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech, 634894) and pooled primers according to the manufacturer's instructions. Quantitative PCR of the amplified cDNAs was performed using Sso Fast EvaGreen Supermix with Low ROX (Bio-Rad Laboratories, 1725210B04), nested primers (Table. S5 ) and the BioMark HD system (Fluidigm) with 96.96 Dynamic Array IFC chip (Fluidigm, BMK-M10-96.96). Cycle threshold values were calculated using Fluidigm's Real-time PCR Analysis software. Log2-transformated expression values were calculated using SINGuLar Analysis Toolset (Fluidigm).
Ribosome Profiling. Ribosome profiling was performed using WT mESCs (n = 2, 1 clone), Nat1 +/-mESCs (n = 3, 3 clones) and Nat1-null mESCs (n = 3, 3 clones). Ribosome-protected mRNA fragments (RPF) and total RNA libraries were prepared using the TruSeq Ribo Profile Mammalian Kit (Illumina) according to the manufacturer's instruction. The obtained libraries were sequenced on NextSeq 500 (illumina). Bases with low quality scores and the adapters in all the sequenced reads were trimmed with cutadapt-1.9.1 (37) . The trimmed reads were mapped to mouse rRNA and tRNA sequences with Bowtie2 version 2.2.8 (38) , and the reads aligned to rRNA or tRNA were excluded from further analysis. The remaining reads were mapped to mouse genome (mm10) using tophat-2.1.0 (39) with GENECODE annotation (GRCm38.p4, Release M10) (40) . The number of reads mapped to each gene was counted by HTSeq-0.6.1 software (41) and normalized with the DESeq2 R/Bioconductor package (v. 1.10.1) (42) . Differentially translated genes were identified with Xtail pipeline (v 1.1.5) (19) .
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protein G (Novex, 10004D) per 30 mg of protein from the cell lysate was washed 3 times with 1 ml 24 of ice-cold PBS using a magnetic separator (Invitrogen, DynaMag) and resuspended in 240 ul of 25 ice-cold PBS on ice. 80 μg of anti-FLAG M2 monoclonal antibody (Sigma, F1804-1MG) per 30 ul 26 of washed Dynabeads protein G was added, and the mixture was rotated gently overnight at 4℃. 27
Cells attached to 10-cm dishes were washed twice with 8 ml of ice-cold PBS on ice. PBS was 28 completely removed, and 2 ml of 0.1% NP-40 cell lysis buffer (50 mM Tris-HCl (pH8.0), 120 mM 29 NaCl, 0.10% NP-40, 1 mM DTT, and 1x cOmplete EDTA-free (Roche, 1873580)) were added to the 30 cell dish. The cells were incubated for 10 min at 4℃ in this condition and then collected into a new 31 tube and homogenized at 7000 rpm for 3 min on ice. The cell lysate was cleared by centrifugation at 32 10000 x g, 4℃ for 10 min. The supernatant of the centrifuged cell lysate was transferred into a new 33 tube, and the protein concentration was measured as input using DU730 (MECMANCOULTER) 34
with Bio-Rad Protein Assay Dye Reagent Concentrate (Bio Rad, #500-006). FLAG 35 antibody-conjugated beads were washed 3 times with 1 ml of 0.1% NP-40 cell lysis buffer, and 36 added into the input, and the mixture was rotated for 3 hr at 4℃. After 3 more washes with 0.1% 37 NP-40 cell lysis buffer and another 3 times with Tris-HCl (pH8.0) buffer (20 mM Tris-HCl, 50 mM 38 NaCl), the beads were re-suspended with 3×FLAG-peptide buffer (100 mM 3× FLAG peptide 39 (Sigma, F4799-4MG), 12 mM SLS, 12 mM SDS, 100 mM Tris-HCl (pH 9.0)) and rotated for 1 hr at 40 4℃ twice to elute the sample from FLAG antibody-conjugated beads. The extract was subjected to 41 whole line LC-MS/MS sequencing and data analysis or Western blots. 42
Statistical Analysis Statistical analysis was performed by GeneSpring GX 12.6, SPSS Statistics 21 43 Table S1 . List of Nat1-and Eif4g1-binding-proteins 
